Estimating the seroprevalence of chikungunya virus exposure in Shimoga district, Karnataka state: A hospital-based study during 2014-2018.


Journal

Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876

Informations de publication

Date de publication:
01 2020
Historique:
received: 30 03 2019
accepted: 24 08 2019
pubmed: 30 8 2019
medline: 11 3 2021
entrez: 30 8 2019
Statut: ppublish

Résumé

Chikungunya fever is a viral disease transmitted to humans by the bite of infected mosquitoes. The disease is characterized by fever, headache, rash, severe joint, and muscle pain. To evaluate the disease burden in the population and the effectiveness of public health measures, periodic seroprevalence surveys are essential. Chikungunya outbreaks were reported from many Asian countries since 2005, after more than three decades of disappearance. The study aimed to estimate the seroprevalence of the chikungunya virus in southern parts of Karnataka state, through demonstrating chikungunya virus-specific neutralizing antibodies. A cross-sectional study was carried out using 509 archived blood samples from a hospital-based acute febrile illness surveillance project, representative of the period between June 2014 and 2018. The study reported a 3.7% seroprevalence of chikungunya virus-neutralizing antibodies in Thirthahalli and Hosanagara taluks of South Karnataka. The low prevalence of chikungunya-neutralizing antibodies indicates that a major population is unexposed and prone to future outbreaks.

Identifiants

pubmed: 31463940
doi: 10.1002/jmv.25581
doi:

Substances chimiques

Antibodies, Neutralizing 0
Antibodies, Viral 0
Immunoglobulin G 0
Immunoglobulin M 0

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

119-123

Subventions

Organisme : ACL HHS
ID : U01GH001051
Pays : United States

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Cheerngod Shilpa (C)

Manipal Institute of Virology, Manipal Academy of Higher Education (Deemed to be University), Manipal, India.

Karunakaran Kavitha (K)

Manipal Institute of Virology, Manipal Academy of Higher Education (Deemed to be University), Manipal, India.

Nittur Sudheesh (N)

Manipal Institute of Virology, Manipal Academy of Higher Education (Deemed to be University), Manipal, India.

Sasidharanpillai Sabeena (S)

Manipal Institute of Virology, Manipal Academy of Higher Education (Deemed to be University), Manipal, India.

Varamballi Prasad (V)

Manipal Institute of Virology, Manipal Academy of Higher Education (Deemed to be University), Manipal, India.

Maity Hindol (M)

Manipal Institute of Virology, Manipal Academy of Higher Education (Deemed to be University), Manipal, India.

Govindakarnavar Arunkumar (G)

Manipal Institute of Virology, Manipal Academy of Higher Education (Deemed to be University), Manipal, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH